Skip to main content
SpringerLink
Log in

Response to the Letter to the Editor: “Association between metformin medication, genetic variation and prostate cancer risk”—genotyping and patient categorization, do they matter?

  • Correspondence
  • Published:
Prostate Cancer and Prostatic Diseases Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Raj GM, Krishnan R Letter to the Editor: “Association between metformin medication, genetic variation and prostate cancer risk” – genotyping and patient categorization, do they matter?. Prostate Cancer Prostatic Dis. 2020. [Epub ahead of print].

  2. Lee MJ, Jayalath VH, Xu W, Lu L, Freedland SJ, Fleshner NE et al. Association between metformin medication, genetic variation and prostate cancer risk. Prostate Cancer Prostatic Dis. 2020. [Epub ahead of print].

  3. Thompson IM, Goodman PJ, Tangen CM, Lucia MS, Miller GJ, Ford LG, et al. The influence of finasteride on the development of prostate cancer. N Engl J Med. 2003;349:215–24.

    Article  CAS  Google Scholar 

  4. Andriole GL, Bostwick DG, Brawley OW, Gomella LG, Marberger M, Montorsi F, et al. Effect of dutasteride on the risk of prostate cancer. N Engl J Med. 2010;362:1192–202.

    Article  CAS  Google Scholar 

  5. Vidal AC, Howard LE, Moreira DM, Castro-Santamaria R, Andriole GL, Freedland SJ. Aspirin, NSAIDs, and risk of prostate cancer: results from the REDUCE study. Clin Cancer Res. 2015;21:756–62.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Urology, Department of Surgery, University of Toronto; Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada

    Min Joon Lee & Robert J. Hamilton

Authors
  1. Min Joon Lee
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Robert J. Hamilton
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Robert J. Hamilton.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Lee, M.J., Hamilton, R.J. Response to the Letter to the Editor: “Association between metformin medication, genetic variation and prostate cancer risk”—genotyping and patient categorization, do they matter?. Prostate Cancer Prostatic Dis 24, 280 (2021). https://doi.org/10.1038/s41391-020-00287-z

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41391-020-00287-z

  • Springer Nature Limited

Search

Navigation